Clinical trial
Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Sirolimus-eluting Coronary Stent System in the Treatment of All-comer Patients With Coronary Artery Disease
NCT04138238 is registered in ClinicalTrials.gov with Sahajanand Medical Technologies Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Sirolimus-eluting Coronary Stent System in the Treatment of All-comer Patients With Coronary Artery Disease
- Lead sponsor
- Sahajanand Medical Technologies Limited
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 19, 2020
- Completion date
- May 31, 2022
- Enrollment
- 1,200 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.